The exosomes show a more pronounced inhibition of Aβ1-42 accumulation and Tau phosphorylation, as well as better therapeutic effects on restoring dendrite length and the density of dendritic spines compared to MSC-EV in the mouse AD model [103]. Here, MAPT is linked to Alzheimer disease.